Find uplifting stories about heroes, innovations, and solutions
9 results for "rna technology"
A single shot that protects against both flu and COVID-19 just got approved in Europe, making vaccinations simpler for millions. The combination vaccine showed stronger immune responses than standard shots in trials with 4,000 adults.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Researchers have developed a breakthrough method that maps brain connections faster and more accurately than ever before, revealing hidden links between neurons that could transform how we detect and treat diseases like Alzheimer's. The technique turns brain mapping into a simple sequencing task.
Scientists at the University of Chicago have developed tiny particles that teach insulin-producing cells to protect themselves from autoimmune attack. The breakthrough could delay or prevent type 1 diabetes without suppressing the entire immune system.
Getting vaccinated just got simpler for millions. European regulators approved the world's first single-shot vaccine that protects against both COVID-19 and seasonal flu for people 50 and older.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.